Mohammad Hassan Jafari Najaf Abadi
Overview
Explore the profile of Mohammad Hassan Jafari Najaf Abadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safaei M, Goodarzi A, Abpeikar Z, Farmani A, Kouhpayeh S, Najafipour S, et al.
Sci Rep
. 2024 Sep;
14(1):22537.
PMID: 39342024
Leishmaniasis is an infectious disease caused by protozoan parasites from different species of leishmania. The disease is transmitted by female sandflies that carry these parasites. In this study, datasets on...
2.
Firouzjaei A, Aghaee-Bakhtiari S, Tafti A, Sharifi K, Jafari Najaf Abadi M, Rezaei S, et al.
Cell Biochem Funct
. 2023 Nov;
41(8):1488-1502.
PMID: 38014635
Colorectal cancer (CRC) is responsible for a significant number of cancer-related fatalities worldwide. Researchers are investigating the therapeutic potential of ferroptosis, a type of iron-dependent controlled cell death, in the...
3.
Roshani M, Rezaian-Isfahni A, Lotfalizadeh M, Khassafi N, Jafari Najaf Abadi M, Nejati M
Cancer Cell Int
. 2023 Nov;
23(1):280.
PMID: 37981671
Gastrointestinal (GI) cancer is a major health problem worldwide, and current diagnostic and therapeutic approaches are often inadequate. Various metallic nanoparticles (MNPs) have been widely studied for several biomedical applications,...
4.
Dashti F, Mirazimi S, Kazemioula G, Mohammadi M, Hosseini M, Razaghi Bahabadi Z, et al.
Pathol Res Pract
. 2022 Dec;
241:154232.
PMID: 36528985
Although extremely rare, malignant melanoma is the deadliest type of skin malignancy with the inherent capability to invade other organs and metastasize to distant tissues. In 2021, it was estimated...
5.
Jafarzadeh A, Noori M, Sarrafzadeh S, Tamehri Zadeh S, Nemati M, Chatrabnous N, et al.
Front Cell Dev Biol
. 2022 Oct;
10:955486.
PMID: 36313570
Downregulated expression of anti-tumor miR-383 has been found in many kinds of cancer. MiR-383 family members can directly target the 3'-untranslated region (3'-UTR) of the mRNA of some pro-tumor genes...
6.
Askarian S, Nasab N, Aghaee-Bakhtiari S, Jafari Najaf Abadi M, Kazemi Oskuee R
Mol Biotechnol
. 2022 Jul;
65(1):97-107.
PMID: 35834121
Selection of targeted and efficient carriers to deliver drugs and genes to cells and tissues is still a major challenge and to overcome this obstacle, aptamers conjugated to nanoparticles have...
7.
Rafiyan M, Jafari Najaf Abadi M, Tamehri Zadeh S, Hamblin M, Mousavi M, Mirzaei H
Front Oncol
. 2022 Jul;
12:917471.
PMID: 35814375
A wide range of microRNAs (miRNAs) are coded for in the human genome and contribute to the regulation of gene expression. MiRNAs are able to degrade mRNAs and/or prevent the...
8.
Rarani F, Rashidi B, Jafari Najaf Abadi M, Hamblin M, Hashemian S, Mirzaei H
Mol Ther Nucleic Acids
. 2022 Jul;
29:219-242.
PMID: 35782361
The coronavirus disease 2019 (COVID-19) pandemic constitutes a global health emergency. Currently, there are no completely effective therapeutic medications for the management of this outbreak. The cytokine storm is a...
9.
Jafari Najaf Abadi M, Khorashadizadeh M, Zarei Jaliani H, Jamialahmadi K, Aghaee-Bakhtiari S
Andrologia
. 2022 Jun;
54(9):e14497.
PMID: 35700742
The inadequate efficacy of the current treatments for metastatic prostate cancer has directed efforts to the discovery of novel therapies. MicroRNAs (miRNAs) have been considered potential therapeutic agents due to...
10.
Jafari Najaf Abadi M, Shafabakhsh R, Asemi Z, Mirzaei H, Sahebnasagh R, Mirzaei H, et al.
Cancer Lett
. 2019 Jun;
459:112-121.
PMID: 31181319
Alternative polyadenylation (APA) is now widely recognized to regulate gene expression. APA is an RNA-processing mechanism that generates distinct 3' termini on mRNAs, producing mRNA isoforms. Different factors influence the...